Merck & Co., Inc. (LON:0QAH)
London · Delayed Price · Currency is GBP · Price in USD 90.10
+1.28 (1.44%)
At close: Oct 3, 2025
Merck & Co. Market Cap
Merck & Co. has a market cap or net worth of 165.31 billion as of October 3, 2025. Its market cap has decreased by -27.41% in one year.
Market Cap
165.31B
Enterprise Value
185.23B
Revenue
46.43B
Ranking
n/a
PE Ratio
13.81
Stock Price
90.10
Market Cap Chart
Since January 2, 1968, Merck & Co.'s market cap has increased from 3.01B to 165.31B, an increase of 5,399.86%. That is a compound annual growth rate of 7.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 3, 2025 | 165.31B | -17.76% |
| Dec 31, 2024 | 201.01B | -7.32% |
| Dec 29, 2023 | 216.89B | -7.10% |
| Dec 30, 2022 | 233.47B | 63.30% |
| Dec 31, 2021 | 142.97B | -5.68% |
| Dec 31, 2020 | 151.58B | -13.30% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 193.12B |
| GSK plc | 66.29B |
| Haleon | 29.39B |
| Smith & Nephew | 11.60B |
| ConvaTec Group | 4.78B |
| Hikma Pharmaceuticals | 4.06B |
| HUTCHMED (China) | 2.03B |
| Genus | 1.67B |